AlphaPrime: Using AI to turbocharge clinical trial processes

$ 6.99

4.8 (698) In stock

Sharon Chen is the CEO of AlphaPrime, a global health technology company. Prior to founding AlphaPrime, Sharon was the head of Verily China (Alphabet’s

Alice Hsu on LinkedIn: Thank you Microsoft & HLTH 2023 at Las Vegas!!!

Clinical Trial: Phase 1b/3 Targeted Alpha-Emitter PRRT RYZ101

Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge

AI can boost clinical trials in 2024. 5 ways it could boost

TechNode

Alice Hsu on LinkedIn: Come join us on 8Feb at 7:30-8:30pm (GMT+8

Branded Content Archives · TechNode

Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge

AlphaPrime: Using AI to turbocharge clinical trial processes

An AI boost for clinical trials

A Phase 2 Open Label Study to Evaluate the Safety and

AI-discovered ALS drug trial uses unique remote monitoring - Drug

AI-discovered ALS drug trial uses unique remote monitoring - Drug

Pandemic-proof recruitment and engagement in a fully decentralized